Gross Margin % is calculated as gross profit divided by its revenue. Perrigo Co's Gross Profit for the
three
months ended in Mar. 2025 was $392 Mil. Perrigo Co's Revenue for the
three
months ended in Mar. 2025 was $1,044 Mil. Therefore, Perrigo Co's Gross Margin % for the quarter that ended in Mar. 2025 was 37.58%.
The historical rank and industry rank for Perrigo Co's Gross Margin % or its related term are showing as below:
PRGO'
s Gross Margin % Range Over the Past 10 Years
Min: 32.69 Med: 36.81 Max: 40.02
Current: 36.38
During the past 13 years, the highestGross Margin % of Perrigo Co was 40.02%. The lowest was 32.69%. And the median was 36.81%.
PRGO's Gross Margin % is ranked worse than 70.74% of 940
companies
in the Drug Manufacturers industry
Industry Median: 47.795
vs PRGO: 36.38
Perrigo Co had a gross margin of 37.58% for the quarter that ended in Mar. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Perrigo Co was -0.90% per year.
Perrigo Co Gross Margin % Historical Data
The historical data trend for Perrigo Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Perrigo Co's Gross Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Perrigo Co's Gross Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Perrigo Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Perrigo Co (NYSE:PRGO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Perrigo Co had a gross margin of 37.58% for the quarter that ended in Mar. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Perrigo Co Gross Margin % Related Terms
Thank you for viewing the detailed overview of Perrigo Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRGO has been successfully added to your 